Back to Search
Start Over
Mechanisms of unconventional CD8 Tc2 lymphocyte induction in allergic contact dermatitis: Role of H 3 /H 4 histamine receptors.
- Source :
-
Frontiers in immunology [Front Immunol] 2022 Oct 07; Vol. 13, pp. 999852. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Histamine (HA) is a potent mediator that plays a central role in inflammation and allergy, acting through four G-protein-coupled receptors (i.e. H <subscript>1</subscript> -H <subscript>4</subscript> ). HA is an accepted promoter of type 2 immunity in CD4 <superscript>+</superscript> T cells during hypersensitivity. Previously, we demonstrated that HA can promote antigen cross-presentation, inducing the activation of antigen-specific CD8 <superscript>+</superscript> T cells in an asthmatic murine model. Non-classical CD8+ T-cell profiles, such as Tc2 or Tc17, are associated with allergic disease persistence and chronicity. In this paper, we focus on the role of the H <subscript>3</subscript> receptor (H <subscript>3</subscript> R) and the H <subscript>4</subscript> receptor (H <subscript>4</subscript> R) in the development of allergic contact dermatitis. We were able to show that induction of the type 2 profiles associated with interleukin 13 production, both by CD4 and CD8 lymphocytes, depend on the interaction of HA with H <subscript>3</subscript> R and H <subscript>4</subscript> R. Blocking both receptors using the selective H <subscript>3</subscript> /H <subscript>4</subscript> receptor antagonist thioperamide or the selective H <subscript>4</subscript> R ligand JNJ777120 reduces the inflammatory response, inducing an immunosuppressive profile associated with the increased proportion of FOXp3 <superscript>+</superscript> regulatory T lymphocytes and CD11b <superscript>+</superscript> Gr-1 <superscript>+</superscript> myeloid suppressor cells. Interestingly, in dendritic cells, only H <subscript>4</subscript> R blockade, and not H <subscript>3</subscript> R blockade, is capable of modulating most of the inflammatory effects observed in our model.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Alcain, Infante Cruz, Barrientos, Vanzulli, Salamone and Vermeulen.)
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 36275674
- Full Text :
- https://doi.org/10.3389/fimmu.2022.999852